Bain Capital Life Sciences Investors, LLC Bluebird Bio, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $662 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding BLUE
# of Institutions
173Shares Held
104MCall Options Held
827KPut Options Held
1.23M-
Black Rock Inc. New York, NY15.2MShares$14.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$10.3 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA7.71MShares$7.56 Million0.35% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$6.26 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.24MShares$6.11 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $75.6M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...